Skip to main content

Chemical Modification of the 3′-Dangling End of Small Interfering RNAs Such as siRNAs and miRNAs: The Development of miRNA Replacement Therapy

  • Chapter
  • First Online:
New Horizons of Process Chemistry

Abstract

The 3′-modified oligonucleotides using aromatic moieties, such as benzene(B)-pyridine(P) analogs (BP-type) and so on, showed prominent nuclease resistance, especially in vivo, and strong RNAi activity. One of non-coding RNAs ranging from 20 to 23 nucleotides in length is naturally occurring microRNAs (miRNAs) that are post-transcriptional regulators of gene expression. The chemically modified miRNAs for genome therapy is easy, inexpensive, and practical. The miRNA replacement therapy using these 3′-modified miRNAs may prove useful for the development of anti-cancer RNA medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Czech, M. P., Aouadi, M., Tesz, G. J., Nat. Rev. Endocrinol., 7, 473–484 (2011).

    Google Scholar 

  2. Lennox, K. A., Behlke, M. A., Gene Therapy, 18, 1111–1120 (2011).

    Google Scholar 

  3. Macrea, I. J., Zhou, K., Li, F., Repic, A., Brooks, A. N., Cande, W. Z., Adams, P. D., Doudna, J. A., Science, 311, 195–198 (2006).

    Google Scholar 

  4. Ueno, Y., Inoue, T., Yoshida, M., Yoshikawa, K., Shibata, A., Kitamura, Y., and Kitade, Y., Bioorg. Med. Chem. Lett., 18, 5194–5196 (2008).

    Google Scholar 

  5. Akao, Y., Nakagawa, Y., Hirata, I., Iio, A., Itoh, T., Kojima, K., Nakashima, R., Kitade, Y., and Naoe, T., Cancer Gene Therapy, 17, 398–408 (2010).

    Google Scholar 

  6. Kitade, Y., Alkao, Y., J. Pharmacol. Sci., 114, 276–280 (2010).

    Google Scholar 

  7. Bader, A. G., Brown, D., Winkler, M., Cancer Res., 70, 7027–7030 (2010).

    Google Scholar 

  8. Noguchi, S., Iwasaki, J., Kumazaki, M., Mori, T, Maruo, K., Sasaki, H., Yamada, N., Shimada, K., Naoe, T., Kitade, Y., Akao, Y., Molecular Ther., 21, 1204–1211 (2013).

    Google Scholar 

  9. Unpublished results.

    Google Scholar 

  10. Kitamura, Y., Masegi, Y., Ogawa, S., Nakashima, R., Akao, Y., Ueno, Y., Kitade, Y., Bioorg. Med. Chem., 21, 4494–4501 (2013).

    Google Scholar 

  11. Noguchi, S., Mori, T., Hoshino, Y., Maruo, K., Yamada, N., Kitade, Y., Naoe, T., Akao, Y., Cancer Lett., 307, 211–220 (2011).

    Google Scholar 

  12. Taniho, K., Nakashima, R., Kandeel, M., Kitamura, Y., Kitade, Y., Bioorg. Med. Chem. Lett., 22, 2518–2521 (2012).

    Google Scholar 

  13. Nagaya, Y., Kitamura, Y., Nakashima, R., Shibata, A., Ikeda, M., Kitade, Y., Nucleosides, Nucleotides and Nucleic Acids, 35, 64–75(2016).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yukio Kitade .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Kitade, Y., Mori, T., Akao, Y. (2017). Chemical Modification of the 3′-Dangling End of Small Interfering RNAs Such as siRNAs and miRNAs: The Development of miRNA Replacement Therapy. In: Tomioka, K., Shioiri, T., Sajiki, H. (eds) New Horizons of Process Chemistry. Springer, Singapore. https://doi.org/10.1007/978-981-10-3421-3_18

Download citation

Publish with us

Policies and ethics